Oded Shahar is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Feb 2022 and Oct 2023: G Medical Innovations Holdings Ltd. (Rehovot, Israel (as filed: L3) — other health care — 2022–2023; $12.1M reported sold to 2 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Benny Tal (3 shared filings), Dror Nuriel-Roth (3 shared filings), Kenneth Melani (3 shared filings), Urs Wettstein (3 shared filings), Yacov Geva (3 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Oded. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Oded Shahar and found 3 differences: Form D filed 26 days after the first sale; Form D filed 28 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.